Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials

被引：16
作者：
Richter, B [1 ]
Berger, M [1 ]
机构：
[1] Univ Dusseldorf, Klin Stoffwechselkrankheiten & Ernahrung, WHO,Collaborating Ctr Diabet, Dept Metab Dis & Nutr, D-40025 Dusseldorf, Germany
来源：
DIABETOLOGIA | 2000年 / 43卷 / 02期
关键词：
D O I：
10.1007/s001250050039
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：254 / 258
页数：5
相关论文
共 48 条
[1]  
Aguilar M, 1999, DIABETIC MED, V16, P716
[2]   Can data-driven benchmarks be used to set the goals of Healthy People 2010? [J].
Allison, J ;
Kiefe, CI ;
Weissman, NW .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (01) :61-65
[3]  
Amer Diabet Assoc, 1998, DIABETES CARE, V21, P2180
[4]  
American Diabetes Association, 1998, DIABETES CARE, pS23
[5]  
[Anonymous], 1990, Diabet Med, V7, P360
[6]  
[Anonymous], 1995, DIABETES, V44, P968
[7]  
Berger M, 1999, DIABETES CARE, V22, pC71
[8]   To bridge science and patient care in diabetes [J].
Berger, M .
DIABETOLOGIA, 1996, 39 (07) :749-757
[9]   Diabetes care and patient-oriented outcomes [J].
Berger, M ;
Mühlhauser, I .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (18) :1676-1678
[10]  
Bernard C, 1984, INTRO ETUDE MED EXPT
12345